Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology » Skin 24. April 2026
Search
medline.ch
Skin
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 7123  Previews Next
   
   Articles 1 - 20 / 142455  
   
Relevance of tumour-infiltrating lymphocytes (TILs) in oral mucosal melanoma: a systematic review.
Int J Oral Maxillofac Surg
Bakhuis CFJ, de Ruiter EJ, de Bree R, Breimer GE, Van Cann EM.
PMID: 42025485 [PubMed - as supplied by publisher]


Differential Melanoma outcomes in men and women: longitudinal findings from a ten-year study.
An Bras Dermatol
Sampaio NM, Cruz FWM, Castro SMO, Oliveira ACR, Martins PR, Cardoso FDS, da Silva SG, Duprat Neto JP, Muglia Amancio A.
PMID: 42025111 [PubMed - as supplied by publisher]


Inverse Relation Between Responses to Pembrolizumab Plus Chemotherapy and Subsequent Cetuximab Plus Paclitaxel in Head and Neck Cancer: Role of the Janus Kinase-Signal Transducer and Activator of Transcription Signaling Pathway.
JCO Precis Oncol
Saijo K, Imai H, Iwasaki T, Ishii R, Higashi K, Ohkoshi A, Yamazaki Y, Shirakawa T, Saito R, Wakayama S, Numakura R, Yoshida Y, Taniguchi S, Kasahara Y, Ouchi K, Komine K, Shirota H, Takahashi M, Suzuki T, Katori Y, Ishioka C, Kawakami H.
PMID: 42024838 [PubMed - indexed for MEDLINE]


Living in your own skin. The experience of the body in melanoma patients: a systematic literature review.
Ital J Dermatol Venerol
Franzoi IG, Granieri A, Sauta MD, Grimaldi C, Mirabile G, Boglione A, Agnesone M, Gonella M, Comandone A.
PMID: 42023886 [PubMed - as supplied by publisher]


Characteristics and prognosis of skin cancer arising from burn scars: a systematic review.
J Plast Surg Hand Surg
Alhadlaq A, Kereet IM, Kamel B, Jahangir K, Hamam NG, Shehab MA, Alamin MH, Osman ASA, Rechid S, Ali MA, Elsaid M.
PMID: 42023819 [PubMed - indexed for MEDLINE]


Metabolic reprogramming in head and neck cancer: therapeutic opportunities and challenges.
J Pharm Pharmacol
Bani-Ahmad E, Dass J, Dass CR.
PMID: 42023694 [PubMed - indexed for MEDLINE]


Quality of Life in a Swedish Cohort of Patients with Mycosis Fungoides.
Acta Derm Venereol
Hub D, Drott K, Belfrage E, Sonesson A.
PMID: 42023497 [PubMed - indexed for MEDLINE]


Case Report: Diagnosis and management of primary malignant melanoma of the bladder: a case-based review.
Front Oncol
Hou X, Xu X, Chen Y, Jiang B, Xu Y, Zhang H.
PMID: 42022322 [PubMed]


Uveal melanoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up.
ESMO Open
Piperno-Neumann S, Angi M, Ascierto PA, Baurain JF, Burgmans MC, Cassoux N, Coupland SE, Dendale R, Fortuna A, Gastaud L, Gutierrez-Miguelez C, Heegaard S, Jager MJ, Kapiteijn E, Keilholz U, Kilic E, Marinkovic M, Moulin A, Nathan P, Patel SP, Pica A, Piulats JM, Ryll B, Sacco JJ, Sauerwein W, Schlaak M, Stedman B, Valente A, Verdijk RM, Verhoef C, Michielin O, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org.
PMID: 42020098 [PubMed - in process]


Histopathological characteristics of secondary enucleation after iodide-125 plaque radiotherapy in Chinese patients with uveal melanoma.
Br J Ophthalmol
Zhang H, Wang H, Liu Y, Luo J, Yin S, Xu X, Wei W.
PMID: 42019982 [PubMed - indexed for MEDLINE]


Single-cell dissection of persistent tumor antigens in non-responders reveals opportunities for TAA-targeted vaccination after neoadjuvant therapy in esophageal squamous cell carcinoma.
J Immunother Cancer
Zhang R, Qi S, Zhou Y, Hu Y, Li Y, Li Y, Qin J, Yang AR, Zhang H, Liu Z, Li Y.
PMID: 42019971 [PubMed - indexed for MEDLINE]


Preoperative computed tomography for assessment of bone invasion in oral squamous cell carcinoma: diagnostic accuracy and anatomical subsite dependency.
J Cancer Res Clin Oncol
Ketschau J, Leonhardt Y, Grabenhorst A, Singer H, Kram H, Krautkremer N, Leopold C, Mohr J, Stimmer H, Wolff KD, Ritschl LM.
PMID: 42017973 [PubMed - indexed for MEDLINE]


Histopathological spectrum of oral squamous cell carcinoma in Naswar users: Correlation with duration, age and site.
J Pak Med Assoc
Iqbal F, Bashir N, Maryam H, Ahmad S.
PMID: 42017720 [PubMed - indexed for MEDLINE]


Diagnostic Utility of PRAME and H3K27me3 in Distinguishing Malignant Melanoma From Proliferative Nodules on Congenital Melanocytic Nevi.
J Cutan Pathol
Hurdogan O, Baykal C, Yilmaz , Erdem BY, Buyukbabani N, Sari SO.
PMID: 42017541 [PubMed - as supplied by publisher]


Retrospective analysis of the optimal timing of immunotherapy in patients with advanced esophageal squamous cell carcinoma: a window of opportunity.
Dis Esophagus
Wang W, Ye L, Ruan K, Li H, Mao W, Ji Y, Xu X.
PMID: 42017418 [PubMed - indexed for MEDLINE]


CRTC1::TRIM11 Cutaneous Tumors With Atypia: Melanoma Mimicry, Aggressive Potential, and Methylation Classifier Limitations.
Genes Chromosomes Cancer
Batson B, Karunamurthy A, Neyaz A, Skaugen JM, Billings SD, Fritchie K, John I.
PMID: 42015602 [PubMed - indexed for MEDLINE]


Rhino-orbito-cerebral Rhizopus delemar infection in a patient with anti-melanoma differentiation-associated-5-positive dermatomyositis diagnosed by metagenomic next-generation sequencing: a case report.
BMC Infect Dis
Peng Z, He H, Zhou S, Qiao L, Wang Q, Li M, Zhao Y.
PMID: 42015023 [PubMed - as supplied by publisher]


Dual Targeting of Akt and MAPK Pathways With Capivasertib and B-Raf Inhibitors Synergistically Suppresses Tumor Growth in B-Raf-Mutated Melanoma Models.
Fundam Clin Pharmacol
Tang J, Zhao L, Zhu Y, Duan B.
PMID: 42014093 [PubMed - indexed for MEDLINE]


Intratumoral sotigalimab with pembrolizumab induces rapid activation of antigen presenting cells and drives anti-tumor responses in non-injected tumors in metastatic melanoma: A phase I/II study.
Cancer Discov
Bentebibel SE, McGrail DJ, Kochat V, Arslan E, Abdel-Wahab R, Pazdrak B, Murthy R, Tahon NHM, Cho SN, Duose DY, Wani K, Liu J, Haymaker C, Gomez JA, Sonnemann H, Katailiha AS, Nassif-Rausseo B, Rahim M, Li I, Mayer AT, Yang X, Hsu FJ, Zhang J, Johnson DH, Amaria RN, Glitza Oliva IC, Patel SP, Hwu P, Elsayes KM, Tawbi HA, Burks JK, Bernatchez C, Davies MA, Rai K, Lizee G, Ekmekcioglu S, Diab A.
PMID: 42013310 [PubMed - as supplied by publisher]


MONETTE: A Randomized Phase II Study of Ceralasertib plus Durvalumab or Ceralasertib Monotherapy in Patients with Advanced Melanoma Resistant to PD-(L)1 Inhibition.
Clin Cancer Res
Schlaak M, Cimminiello C, Pigozzo J, Lee J, Grabbe S, Rutkowski P, Mackiewicz J, Tsai KK, Ascierto PA, Mandalà M, Carnevale-Schianca F, Haferkamp S, Atkinson V, Hassel JC, Sandhu S, Sharfman W, Dean E, Noor U, Iyer S, Rabbie R, Ribas A.
PMID: 42012456 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 142455    Page 1 of 7123  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1